Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
02/2014
02/12/2014CN103565757A Recombinant human interleukin-2 freeze-dried preparation for injection and preparation method thereof
02/12/2014CN103565756A Preparation method of miriplatin freeze-drying preparation
02/12/2014CN103565754A Calcium folinate composition for injection and preparation method thereof
02/12/2014CN103564111A Toxin expelling and tumor removing tea
02/12/2014CN103102399B Anti-tumor protein extracted from pholiota nameko and preparation method of antineoplastic protein
02/12/2014CN103083550B Oral liquid for preventing and treating gastric cancer and preparation method thereof
02/12/2014CN102988479B Preparation method and application of anti-dazzling tablet
02/12/2014CN102973616B High-bioactivity ganoderma spore oil and supercritical preparation method thereof
02/12/2014CN102935204B Traditional Chinese medicine preparation for treating hysteromyoma
02/12/2014CN102906086B Quinazoline compounds
02/12/2014CN102861023B Application of saringosterol
02/12/2014CN102786458B Pyrrole formamide derivative, and preparation method and application thereof
02/12/2014CN102786434B Acetaminophen acid derivative, preparation method and application thereof
02/12/2014CN102786432B Acetaminophen ester derivative, preparation process and use thereof
02/12/2014CN102643225B Ionic liquid, nano fluorescent ellipsoid and preparation method thereof
02/12/2014CN102633895B Extraction and preparation method by comprehensively utilizing liquorice
02/12/2014CN102596937B Compounds and compositions as protein kinase inhibitors
02/12/2014CN102424693B Tetra-2,6-dipicolinic acid-di-(ferrocenedicarboxylic acid)triphenyl tin complex, and its preparation method and application
02/12/2014CN102397510B Compound propolis composition for treating chicken Marek's disease and preparation method thereof
02/12/2014CN102366464B Antitumor traditional Chinese medicine composition
02/12/2014CN102153488B Alpha,beta-diamino acid derivative, synthetic method thereof and application thereof
02/12/2014CN101985428B O-anilino benzoic acid derivatives or pharmaceutically acceptable salts thereof as well as preparation method and application thereof
02/12/2014CN101918442B Anti-VEGF antibodies
02/12/2014CN101704892B Anti-uPAR humanized antibody, coding gene and application thereof
02/12/2014CN101700323B Pharmaceutical composition for preventing and treating liver cancer
02/11/2014US8648185 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
02/11/2014US8648171 Members of the FC receptor homolog gene family (FcRH1-3,6) related reagents and uses thereof
02/11/2014US8648108 Medical compositions for intravesical treatment of bladder cancer
02/11/2014US8648068 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions
02/11/2014US8648066 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
02/11/2014US8648051 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
02/11/2014US8648047 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
02/11/2014US8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
02/11/2014US8647820 Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription
02/11/2014US8647603 Devices and methods for the treatment of cancer
02/11/2014CA2792950C 5-(optionally substituted phenyl) pyridin-2-yl compounds as metalloenzyme inhibitors
02/11/2014CA2778291C Akt inhibitors
02/11/2014CA2755285C Inhibitors of pi3 kinase
02/11/2014CA2738563C 8-substituted isoquinoline derivatives and the use thereof
02/11/2014CA2631868C Treatment of drug-resistant tumors
02/11/2014CA2617312C Noninvasive measurement of chemical substances
02/11/2014CA2611401C Oxindoles as kinase inhibitors
02/11/2014CA2599643C Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
02/11/2014CA2582247C 3-arylamino pyridine derivatives
02/11/2014CA2560042C Hmb compositions and uses thereof
02/11/2014CA2559187C Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
02/11/2014CA2549662C A method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity
02/11/2014CA2531565C Production of poxviruses with adherent or non adherent avian cell lines
02/11/2014CA2529496C Anti-cd74 immunoconjugates and methods
02/11/2014CA2471363C Albumin fusion proteins
02/11/2014CA2469266C The method of treating cancer
02/11/2014CA2437038C Method of determining a chemotherapeutic regimen based on ercc1 and ts expression
02/11/2014CA2421751C Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
02/11/2014CA2388045C Nucleic acid immunogenic compositions encoding hsp-antigen chimera
02/11/2014CA2387184C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
02/11/2014CA2357986C Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
02/11/2014CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
02/06/2014WO2014022858A1 Enzyme-activating compounds and compositions
02/06/2014WO2014022784A2 Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis
02/06/2014WO2014022774A1 Treatment induced damage to the tumor micro-environment promotes cancer therapy resistance through extracellular proteins
02/06/2014WO2014022752A1 Macrocycles as pim inhibitors
02/06/2014WO2014022728A1 Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer
02/06/2014WO2014022660A1 Curcumin analogs and methods of making and using thereof
02/06/2014WO2014022271A1 Method of treating metastatic cancer
02/06/2014WO2014022237A1 Amorphous cabazitaxel
02/06/2014WO2014021795A1 Method of administrating a series of compositions for dynamic immune modulation
02/06/2014WO2014021693A2 Novel monoclonal antibody which is specifically bound to tm4sf5 protein and use thereof
02/06/2014WO2014021667A1 Composition for treating cancer associated with hpv infection
02/06/2014WO2014021591A2 Novel compound, method for preparing same and pharmaceutical composition comprising same
02/06/2014WO2014021408A1 Method for treating cancer by anticancer agent co-administration
02/06/2014WO2014021389A1 Peptide capable of inhibiting mate activity
02/06/2014WO2014021339A1 Monoclonal antibody against human midkine
02/06/2014WO2014021337A1 Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
02/06/2014WO2014020922A1 Antibody and functional fragment thereof capable of treating diseases associated with hematopoietic stem cell transplantation such as graft-versus-host disease, and pharmaceutical composition comprising same
02/06/2014WO2014020553A1 Salts of pralatrexate
02/06/2014WO2014020531A1 Imidazo[1,2-b]pyridazin-6-amine derivatives as kinase jak-2 inhibitors
02/06/2014WO2014020351A1 Receptor antagonists
02/06/2014WO2014020350A1 Par2 receptor antagonists
02/06/2014WO2014020264A1 Novel iron complexes capable of detecting a nitro-reducing chemical or biochemical entity, in particular by in vivo mri, and in vitro detection method
02/06/2014WO2014020211A1 Breast cancer cell line and use thereof in the identification of candidate compounds for the treatment of said disease
02/06/2014WO2014020160A1 Article of manufacture comprising aflibercept or ziv-aflibercept
02/06/2014WO2014020105A1 Griseofulvin derivatives
02/06/2014WO2014020101A1 Griseofulvin derivatives
02/06/2014WO2014020012A1 Quinone compounds and their uses for the treatment of cancer
02/06/2014WO2014019908A2 Substituted pyrroles active as kinases inhibitors
02/06/2014WO2014019685A1 Novel chartreusin analogues
02/06/2014WO2014019520A1 Tumor vessel specific binding polypeptide and application thereof
02/06/2014WO2014019468A1 Piperazinotrizole compound, preparation method therefor, and use thereof in drug preparation
02/06/2014WO2014019338A1 Protein kinase inhibitors
02/06/2014WO2013170364A9 Sparc polypeptide and collagen-iv matrix for sensitizing cancer cells to a chemotherapeutic agent
02/06/2014WO2013166594A8 Heteromultimer constructs of immunoglobulin heavy chains with mutations in the fc domain
02/06/2014WO2013004076A8 Agr2 blocking antibody and use thereof
02/06/2014US20140038980 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
02/06/2014US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
02/06/2014US20140038947 Therapeutic applications of pro-apoptotic benzodiazepines
02/06/2014US20140037673 Polyvalent conjugate vaccine for cancer
02/06/2014US20140037644 Prospective Identification and Characterization of Breast Cancer Stem Cells
02/06/2014US20140037616 Immunoglobulin 1
02/06/2014US20140037589 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
02/05/2014EP2692777A1 Pharmaceutical composition containing block copolymer comprising boric acid compound
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 2211